| Synergy Pharmaceuticals, Inc. (SGYP.OB) is a public, development-stage biopharmaceutical company focused on drugs to treat gastrointestinal (GI) conditions and diseases. Our drug development program and patent estate are based on a class of synthetic peptides designed to mimic uroguanylin, a human hormone that regulates intestinal fluid transport. Our drug candidates were discovered and developed in-house by Synergy scientists and are covered by extensive patents. |
